VANDA PHARMACEUTICALS INC (VNDA)
Currency USD
Company Overview
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.
Contact Details
- Address
- 2200 PENNSYLVANIA AVE NW SUITE 300E
- City
- WASHINGTON
- State
- DC
- Country
- USA
- Zip Code
- 20037
- Phone Number
- 202-734-3400
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...